Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B

This publication has 24 references indexed in Scilit:

• A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor
  Journal of Biological Chemistry, 1998
• Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic Properties
  Published by Elsevier ,1998
• The Plasma Carboxypeptidases and the Regulation of the Plasminogen System
  Trends in Cardiovascular Medicine, 1997
• TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex
  Published by Elsevier ,1996
• Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
  Circulation, 1994
• Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide
  Biochemistry, 1992
• Purification and characterization of a new arginine carboxypeptidase in human serum
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1990
• Molecular modeling of protein-glycosaminoglycan interactions.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
• Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis
  European Journal of Biochemistry, 1984
• A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N
  Biochemical and Biophysical Research Communications, 1981